NATIONAL RESEARCH CORP
For the period ended Sep 30, 2024. Filed Nov 8, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2024 · Filed Nov 8, 2024
NRC$26.67+3.1%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Balance Sheets
(In thousands, except share amounts and par value)
| September 30, 2024 | December 31, 2023 | |
|---|---|---|
| (unaudited) | ||
| Assets | ||
| Current assets: | ||
| Cash and cash equivalents | $3,461 | $6,653 |
| Trade accounts receivable, less allowance for doubtful accounts of $45 and $75, respectively | 11,059 | 12,378 |
| Prepaid expenses | 4,871 | 4,228 |
| Income taxes receivable | 645 | 161 |
| Other current assets | 664 | 940 |
| Total current assets | 20,700 | 24,360 |
| Property and equipment, net | 36,320 | 28,205 |
| Intangible assets, net | 2,713 | 1,471 |
| Goodwill | 66,209 | 61,614 |
| Other noncurrent assets | 5,856 | 6,787 |
| Total assets | $131,798 | $122,437 |
| Liabilities and Shareholders’ Equity | ||
| Current liabilities: | ||
| Current portion of notes payable, net of unamortized debt issuance costs | $3,721 | $7,214 |
| Line of credit | 5,000 | - |
| Accounts payable | 2,588 | 1,301 |
| Accrued wages and bonuses | 5,392 | 3,953 |
| Accrued expenses | 6,279 | 4,893 |
| Dividends payable | 2,817 | 2,906 |
| Deferred revenue | 17,301 | 14,834 |
| Income taxes payable | - | 222 |
| Contingent consideration | 506 | - |
| Other current liabilities | 673 | 880 |
| Total current liabilities | 44,277 | 36,203 |
| Notes payable, net of current portion and unamortized debt issuance costs | 44,910 | 29,470 |
| Deferred income taxes | 4,131 | 4,139 |
| Contingent consideration, net of current portion | 293 | - |
| Other long-term liabilities | 3,564 | 3,670 |
| Total liabilities | 97,175 | 73,482 |
| Shareholders’ equity: | ||
| Preferred stock, $0.01 par value, authorized 2,000,000 shares, none issued | - | - |
| Common stock, $0.001 par value; authorized 110,000,000 shares, issued 31,072,144 in 2024 and 31,002,919 in 2023, outstanding 23,476,040 in 2024 and 24,219,887 in 2023 | 31 | 31 |
| Additional paid-in capital | 180,061 | 178,213 |
| Retained earnings (accumulated deficit) | (20,855) | (30,530) |
| Treasury stock, at cost; 7,596,104 Common shares in 2024 and 6,783,032 Common shares in 2023 | (124,614) | (98,759) |
| Total shareholders’ equity | $34,623 | $48,955 |
| Total liabilities and shareholders’ equity | $131,798 | $122,437 |
See accompanying notes to condensed consolidated financial statements
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.